The Effect of Ticagrelor on the Inflammatory Response to Human Endotoxemia

Trial Profile

The Effect of Ticagrelor on the Inflammatory Response to Human Endotoxemia

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 Jul 2016

At a glance

  • Drugs Ticagrelor (Primary) ; Aspirin; Clopidogrel; Prasugrel
  • Indications Cardiovascular disorders
  • Focus Pharmacokinetics
  • Acronyms TICA-LPS
  • Most Recent Events

    • 14 Dec 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
    • 25 Nov 2015 New source identified and integrated- ClinicalTrials.gov
    • 07 Jul 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top